Prothena Corp (Prothena) discovers and develops therapies for the treatment of neurological disorders ... compared to a revenue of US$0.1 million the previous quarter. For a complete picture of ...
Protalix's PRX-115 shows promising Phase 1 data for chronic refractory gout, with long-term urate reduction after a single dose, but faces significant competition and safety concerns. Protalix's ...
The group, which took over the country by force in 2021 after the US withdrawal, also reportedly prevents women from getting treatment from male doctors unless a male guardian is present. Human rights ...
Despite being a first-line treatment for adolescent depression and anxiety, antidepressant drugs appear to have questionable efficacy and carry an increased risk of adverse effects in this population.